Clinical Trial Update: Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating the safety of transplanting human glial restricted progenitor cells in subjects with transverse myelitis is in Phase 1/Phase 2, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transverse Myelitis

Drugs mentioned

• glial restricted progenitor cells (hGRP) transplantation

Snippet

Sponsor: Q Therapeutics, Inc. | Conditions: Transverse Myelitis | Phase 1, Phase 2 | Status: UNKNOWN